CNBC World

Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge

Eli Lilly now expects 2026 revenue to come in between $85 billion and $87 billion, up from a previous guidance of $82 billion and $85 billion.

This is a short WorldPing brief. The full report was published by CNBC World.

Read the full report at CNBC World

Related news

Sweltering summer lifts Next sales as profit outlook upgraded againWorldPing
The Guardian

Sweltering summer lifts Next sales as profit outlook upgraded again

Clothing and homeware retailer says growth led by suite of alternative brands and strong online sales Next has raised hopes that UK shoppers are still willing to spend despite pressures on household budgets, after the hot summer boosted its clothing sales.

Brief by WorldPing · Original reporting by The Guardian